Phosphoglucose Isomerase Is Important for Aspergillus fumigatus Cell Wall Biogenesis.
Yao ZhouKaizhou YanQijian QinOlawale G RaimiChao DuBin WangChukwuemeka Samson AhamefuleBartosz KowalskiCheng JinDaan M F van AaltenWenxia FangPublished in: mBio (2022)
Aspergillus fumigatus is a devastating opportunistic fungal pathogen causing hundreds of thousands of deaths every year. Phosphoglucose isomerase (PGI) is a glycolytic enzyme that converts glucose-6-phosphate to fructose-6-phosphate, a key precursor of fungal cell wall biosynthesis. Here, we demonstrate that the growth of A. fumigatus is repressed by the deletion of pgi , which can be rescued by glucose and fructose supplementation in a 1:10 ratio. Even under these optimized growth conditions, the Δ pgi mutant exhibits severe cell wall defects, retarded development, and attenuated virulence in Caenorhabditis elegans and Galleria mellonella infection models. To facilitate exploitation of A. fumigatus PGI as an antifungal target, we determined its crystal structure, revealing potential avenues for developing inhibitors, which could potentially be used as adjunctive therapy in combination with other systemic antifungals. IMPORTANCE Aspergillus fumigatus is an opportunistic fungal pathogen causing deadly infections in immunocompromised patients. Enzymes essential for fungal survival and cell wall biosynthesis are considered potential drug targets against A. fumigatus. PGI catalyzes the second step of the glycolysis pathway, linking glycolysis and the pentose phosphate pathway. As such, PGI has been widely considered as a target for metabolic regulation and therefore a therapeutic target against hypoxia-related diseases. Our study here reveals that PGI is important for A. fumigatus survival and exhibit pleiotropic functions, including development, cell wall glucan biosynthesis, and virulence. We also solved the crystal structure of PGI, thus providing the genetic and structural groundwork for the exploitation of PGI as a potential antifungal target.
Keyphrases
- cell wall
- candida albicans
- crystal structure
- staphylococcus aureus
- pseudomonas aeruginosa
- biofilm formation
- type diabetes
- endothelial cells
- human health
- intensive care unit
- adipose tissue
- prognostic factors
- ejection fraction
- antimicrobial resistance
- mesenchymal stem cells
- early onset
- metabolic syndrome
- acute respiratory distress syndrome
- skeletal muscle
- drug induced
- risk assessment
- smoking cessation
- weight loss
- patient reported outcomes
- free survival
- wild type